Management of LDL-cholesterol With Inclisiran + Usual Care Compared to Usual Care Alone in Participants With a Recent Acute Coronary Syndrome
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 400 participants.
Also called NCT04873934
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 400 participants
- Sponsor
- Registry
-
NCT04873934
-
- Other papers using this trial's data
- Low-Density Lipoprotein Cholesterol Lowering With Inclisiran Plus Usual Care in Recent Acute Coronary Syndrome: VICTORION-INCEPTION, a Randomized, Controlled, Open-Label Trial
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT04873934. Randomized; no masking; primary purpose treatment. Start 2021-06-24 (actual); primary completion 2024-08-07 (actual). Results posted on 2025-08-21.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Management of LDL-cholesterol With Inclisiran + Usual Care Compared to Usual Care Alone in Participants With a Recent Acute Coronary Syndrome
- Acronym
- V-INCEPTION
- Condition
- Acute Coronary Syndrome
- Intervention (Drug)
- Inclisiran
- Lead sponsor
- Novartis Pharmaceuticals
Record details
- Record id
cardio:ct-nct04873934- Content hash
cb7d789e49ac22da442c88ee1999017a749d63879b7964d713b81ce38a5f6aa0